Apoptosis in atherosclerosis: Beneficial or detrimental?

Cardiovascular Research

Volumn 45, Issue 3, 2000, Pages 736-746

  Kockx, Mark M ^a,b   Herman, Arnold G ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Apoptosis; Atherosclerosis; Lipid metabolism; Macrophages; Smooth muscle

Indexed keywords

COLLAGEN FIBER; COLLAGEN TYPE 1; DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PROTEIN P21; PROTEIN P53; THROMBIN;

APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; DNA REPAIR; DNA SYNTHESIS; HUMAN; LIPID METABOLISM; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; THROMBOSIS;

APOPTOSIS; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; LIPID METABOLISM; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PHAGOCYTOSIS;

EID: 0033984624     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00235-7     Document Type: Review

References (98)

1. Virchow R. Die Cellularpathologie: Sechszehnte verlesung, 14 April 1858, George Olms, Hildesheim, Germany, 1966:317-329.
2. Imai H., Thomas W.A. Cerebral atherosclerosis in swine: Role of necrosis in progression of diet-induced lesions from proliferative to atheromatous stage. Exp Mol Pathol. 8:1968;330-357.
3. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Brit J Cancer. 26:1972;239-257.
4. Saunders J.W. Death in embryonic systems. Science. 154:1966;604-612.
5. Cho A., Cantman D.W., Langille B.L. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 76:1995;168-175.
6. Slomp J., Gittenberger-de Groot A.C., Glukhova M.A., et al. Differentiation, dedifferentiation and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler Thromb Vasc Biol. 17:1997;1003-1009.
7. Isner J.M., Kearney M., Bortman S., Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 91:1995;2703-2711.
8. Hegyi L., Skepper J.N., Cary N.R., Mitchinson M.J. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J Pathol. 180:1996;423-442.
9. Kockx M.M., De Meyer G.R.Y., Muhring J., et al. Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits. Atherosclerosis. 120:1996;115-124.
10. Geng Y.-J., Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin 1β converting enzyme. Am J Path. 147:1995;251-266.
11. Han D.K.M., Haudenschild C.C., Hong M.K., et al. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 147:1995;267-277.
12. Björkerud S., Björkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol. 149:1996;367-380.
13. Mallat Z., Ohan J., Lesèche G., Tedgui A. Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation. 96:1997;424-428.
14. Newby A.C., George S.J. Proliferation, migration, matrix turnover and death of smooth muscle cells in native coronary and vein graft atherosclerosis. Curr Opin Cardiol. 11:1996;574-582.
15. Bauriedel G., Schluckebier S., Hutter R., et al. Apoptosis in restenosis versus stable angina atherosclerosis. Implications for the pathogenesis of restenosis. Arterioscler Thromb Vasc Biol. 18:1998;1132-1139.
16. Kockx M.M., De Meyer G.R.Y., Bortier H., et al. Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. Circulation. 94:1996;1255-1262.
17. Kockx M.M., De Meyer G.R.Y., Muhring J., et al. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 97:1998;2307-2315.
18. Bennett M.R., Evan G.I., Schwartz S.M. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 95:1995;2266-2274.
19. Kockx M.M. Apoptosis in the atherosclerotic plaque. Quantitative and qualitative aspects. Arterioscler Thromb Vasc Biol. 18:1998;1519-1522.
20. Kockx M.M., Herman A.G. Apoptosis in atherogenesis: Implications for plaque destabilization. Eur Heart J. 19:(Suppl. G):1998;G23-G28.
21. Bennett M.R. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Research. 41:1999;361-368.
22. Pollman M.J., Hall J.L., Mann M.J., Zhang L Gibbons G.H. Inhibition of neointimal cell Bcl-x expression induces apoptosis and regression of vascular disease. Nat Med. 4:1998;222-227.
23. Wang B.Y., Ho H.K.V., Lin P.S., et al. Regression of atherosclerosis: Role of nitric oxide and apoptosis. Circulation. 99:1999;1236-1241.
24. Hegyi L., Hardwick S.J., Mitchinson M.J. Letter to the editor. Am J Pathol. 105:1997;371-373.
25. Kockx M.M., Muhring J., Knaapen M.W.M., De Meyer G.R.Y. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol. 152:1998;885-888.
26. Casciola-Rosen L.A., Miller D.K., Anhalt G.J., Rosen A. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem. 269:1994;30757-30760.
27. Kanoh M., Takemura G., Misao J., et al. Of the significance of myocytes with positive DNA in situ nick end labeling (TUNEL) in hearts with dilated cardiomyopathy: Not apoptosis but DNA repair. Circulation. 99:1999;2757-2764.
28. Murer-Orlando M.L., Peterson A.C. In situ nick translation of human and mouse chromosomes detected with biotinylated nucleotide. Exp Cell Res. 157:1985;322-334.
29. Adolph S., Hamaster H. In situ nick translation of metaphase chromosomes with biotin-labelled d-UTP. Hum Genet. 69:1985;117-121.
30. Lutgens E., Daemen M., Kockx M., et al. Atherosclerosis in APOE*3-Leiden transgenic mice: From proliferative to atheromatous stage. Circulation. 99:1999;276-283.
31. Lutgens E., De Muinck E.D., Kitslaar P.J., et al. Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovasc Research. 41:1999;473-479.
32. Bennett M.R., Evan G.I., Newby A.C. Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ Res. 74:1994;525-536.
33. Bochaton-Piallat M.L., Gabbiani F., Redard M., Desmoulière A., Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 146:1995;1059-1064.
34. Boyle J.J., Bowyer D.E., Proudfoot D., Weisberg P.L., Bennett M.R. Human monocyte/macrophages induce human vascular smooth muscle cell apoptosis in culture. Circulation. 98:(Suppl. I):1998;598.
35. Dimmeler S., Hermann C., Zeiher A.M. Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? Eur Cytokine Netw. 9:1998;697-698.
36. Du X.L., Sui G.Z., Stockklauser-Farber K., Weiss J., Zink S., Schwippert B., Wu Q.X., Tschope D., Rosen P. Introduction of apoptosis by high pro-insulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. Diabetologia. 41:1998;249-256.
37. Dimmeler S., Haendeler J., Galle J., Zeiher A.M. Oxidized low density lipoprotein induces apoptosis of human endothelial cells by activation of CPP-32 like proteases. Circulation. 95:1997;1760-1763.
38. Lizard G., Lemaire S., Monier S., Gueldry S., Neel D., Gambert P. Induction of apoptosis and of interleukin-1 beta secretion by 7-beta-hydroxycholesterol and 7-ketocholesterol: Partial inhibition by Bcl-2 overexpression. FEBS Lett. 419:1997;276-280.
39. Dimmeler S., Rippmann V., Weiland U., Haendeler J., Zeiher A.M. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res. 81:1997;970-976.
40. Polte T., Oberle S., Schröder H. Nitric oxide protects endothelial cells from tumor necrosis factor-α-induced cytotoxicity: Possible involvement of cyclic GMP. FEBS Lett. 409:1997;46-48.
41. Dimmeler S., Haendeler J., Nehls M., Zeiher A.M. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1α-converting enzyme (Ice)-like and cystein protease protein (CPP)-32-like protease. J Exp Med. 185:1997;601-607.
42. Dimmeler S., Haendeler J., Sause A., Zeiher A.M. Nitric oxide inhibits Apo-1/Fas-mediated cell death. Cell Growth Diff. 9:1998;415-422.
43. Buttery L.D.K., Springall D.R., Chester A.H., et al. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 75:1996;77-85.
44. Wilcox J.N., Subramanian R.R., Sundell C.L., et al. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol. 17:1997;2479-2488.
45. Luoma J.S., Strålin P., Marklund S.L., et al. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 18:1998;157-167.
46. Esaki T., Hayashi T., Muto T., et al. Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits. Atherosclerosis. 128:1997;39-46.
47. Beckmann J.S., Ye Y.Z., Anderson P.G., et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 375:1994;81-88.
48. Cromheeke K.M., Kockx M.M., De Meyer G.R.Y., et al. Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. Cardiovasc Research. 9:(43):1999;744-754.
49. Libby P. Molecular bases of acute coronary syndromes. Circ. 91:1993;2844-2850.
50. Davies M.J. Stability and instability: Two faces of coronary atherosclerosis. Circulation. 94:1996;2013-2020.
51. Libby P., Geng Y.J., Aikawa M., et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol. 7:1996;330-335.
52. Arroyo L.H., Lee R.T. Mechanism of plaque rupture: Mechanical and biologic interactions. Cardiovasc Research. 41:1999;369-375.
53. Van der Wal A.C., Becker A.E. Atherosclerotic plaque rupture - Pathologic basis of plaque stability and instability. Cardiovasc Research. 41:1999;334-344.
54. Gallis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 94:1994;2493-2503.
55. Newby A.C., Zaltsman A.B. Fibrous cap formation or destruction - The critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc Research. 41:1999;345-360.
56. Rekhter M.D. Collagen synthesis in atherosclerosis: Too much and not enough. Cardiovasc Research. 41:1999;376-384.
57. Ang A.H., Tachas G., Campbell J.H., Bateman J.F., Campbell G.R. Collagen synthesis by cultured rabbit aortic smooth-muscle cells. Alteration with phenotype. Biochem J. 265:1999;461-469.
58. Rekhter M.D., Gordon D. Cell proliferation and collagen synthesis are two independent events in human atherosclerotic plaques. J Vasc Res. 31:1994;280-286.
59. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell. 80:1995;293-299.
60. Iacopetta B., Wysocki S., Norman P., House A. The p53 tumour suppressor gene is overexpressed but not mutated in human atherosclerotic tissue. Int J Oncol. 7:1995;399-402.
61. Woo R.A., McLure K.G., Lees-Miller S.P., Rancourt D.E., Lee P.W. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature. 394:1998;700-704.
62. Kockx M.M., De Meyer G.R.Y., Buyssens N., et al. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res. 83:1998;378-387.
63. Ross R., Wight T.N., Strandness E., Thiele B. Human atherosclerosis I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol. 114:1984;79-93.
64. Stehbens W.E. Cerebral atherosclerosis: Intimal proliferation and atherosclerosis in the cerebral arteries. Arch Pathol. 999:1975;582-591.
65. Geng Y.J., Henderson L.E., Levesque E.B., Muszynski M., Libby P. Involvement of the Fas death-signalling pathway in cytokine-induced apoptosis of vascular smooth muscle cells during atherogenesis. Arterioscler Thromb Vasc Biol. 17:1997;2200-2208.
66. Cai W., Devaux B., Schaper W., Schaper J. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis. 131:1997;177-186.
67. Dong C., Wilson J.E., Winters G.L., Mc Manus B.M. Human transplant coronary artery disease: Pathologic evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy. Lab Invest. 74:1996;921-931.
68. Best P.J.M., Hasdai D., Sangiorgi G., et al. Apoptosis. Basic concepts and implications in coronary artery disease. Arterioscler Thromb Vasc Biol. 19:1999;14-22.
69. Flynn P.D., Byrne C.D., Baglin T.P., Weissberg P.L., Bennett M.R. Thrombin generation by apoptotic vascular smooth muscle cells. Blood. 89:1997;4378-4384.
70. Wink D.A., Kasprzak K.S., Maragos C.M., et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254:1991;1001-1003.
71. Nguyen T., Brunson D., Crespi C.L., Penman B.W., Wishnok J.S., Tannenbaum S.R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA. 89:1998;3030-3034.
72. De Rojas-Walker T., Tamir S., Ji H., Wishnok J.S., Tannenbaum S.R. Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem Res Toxicol. 8:1995;473-477.
73. White E. P53, guardian Of Rb. Nature. 371:1994;21-22.
74. Ihling C., Menzel G., Wellens E. Topographical association between cyclin-dependent kinases inhibitor p21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscler Thromb Vasc Biol. 17:1997;2218-2224.
75. Meßmer U.K., Reed J.C., Brüne B. Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J Biol Chem. 271:1996;20192-20197.
76. Guevara N.V., Kim H.S., Antonova E.I., Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med. 5:1999;335-339.
77. Althaus F.R., Richter C. ADP ribosylation of proteins - Enzymology and biological significance. Mol Biol Biochem Biophys. 37:1997;1-125.
78. De Murcia G., Menessier-De Murcia J. Poly(ADP-ribose) polymerase: A molecular nick-sensor. Trends Biochem Sci. 19:1994;172-176.
79. Szabo C., Zingarelli B., O'Connor M., Salzman A.L. DNA strand breakage, activation of poly(ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA. 93:1996;1753-1758.
80. Henry Y., Lepoivre M., Drapier J.C., et al. Epr characterization of molecular targets for NO in mammalian cells and organelles. Faseb J. 7:1993;1124-1134.
81. Kim Y.K., Talanian R.V., Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem. 272:1997;31138-31148.
82. Melino G., Bernassola F., Knight R.A., et al. S-Nitrosylation regulates apoptosis. Nature. 388:1997;432-433.
83. Mannick J.B., Hausladen A., Liu L., et al. Fas-induced caspase denitrosylation. Science. 284:1999;651-654.
84. Platt N., da Silva R.P., Gordon S. Recognizing death: The phagocytosis of apoptotic cells. Trends Cell Biol. 8:1998;365-372.
85. Savill J. Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull. 53:1997;491-508.
86. Sambrano G.R., Parthasarathy S., Steinberg D. Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. Proc Natl Acad Sci USA. 91:1994;3265-3269.
87. Sambrano G.R., Steinberg D. Recognition of oxidatively and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: Role of membrane phosphatidylserine. Proc Natl Acad Sci USA. 92:1995;1396-1400.
88. Steinberg D., Lewis A. Conner Memorial Lecture: Oxidative modification of LDL and atherogenesis. Circulation. 95:1997;1062-1071.
89. Burke T.M., Sandstrom P.A. Oxidative stress as a mediator of apoptosis. Immunol Today. 15:1994;7-10.
90. Krieger M. The other side of scavenger receptors: Pattern recognition for host defense. Curr Opin Lipidol. 8:1997;275-280.
91. Knies U.E., Behrensdorf H.A., Mitchell C.A., et al. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. Proc Natl Acad Sci USA. 95:1998;12322-12327.
92. Kao J., Houck K., Fan Y., et al. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. J Biol Chem. 269:1994;25106-25119.
93. Loegering D.J., Raley M.J., Reho T.A., Eaton J.W. Macrophage dysfunction following the phagocytosis of IgG-coated erythrocytes: Production of lipid peroxidation products. J Leukoc Biol. 59:(3):1996;357-362.
94. Bombeli T., Karsan A., Tait J.F., Harlan J.M. Apoptotic vascular endothelial cells become procoagulant. Blood. 89:(7):1997;2429-2442.
95. Greeno E.W., Bach R.R., Moldow C.F. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest. 75:1996;281-289.
96. Toschi V., Gallo G., Lettino M., et al. Tissue factor modulates thrombogenicity of human atherosclerotic plaques. Circulation. 95:1997;594-599.
97. Mallat Z., Hugel B., Ohan J., et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity. Circulation. 99:1999;348-353.
98. Aikawa M., Rabkin E., Okada Y., et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: A potential mechanism of lesion stabilization. Circulation. 97:1998;2433-2444.